Zhang Junge 4
4 · Ocugen, Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Zhang Junge
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-03$0.51/sh+39,000$19,890→ 39,000 total - Exercise/Conversion
Common Stock
2022-03-03$1.83/sh+49,000$89,670→ 88,000 total - Exercise/Conversion
Option (Right to Buy)
2022-03-03+39,000→ 15,000 totalExercise: $0.51Exp: 2030-01-02→ Common Stock (39,000 underlying) - Exercise/Conversion
Option (Right to Buy)
2022-03-03+49,000→ 77,000 totalExercise: $1.83Exp: 2031-01-01→ Common Stock (49,000 underlying)
Holdings
- 876,904(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.
- [F2]The options, initially representing a right to purchase 126,000 shares, vest and become exercisable in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.